Upon immunogenic challenge, lymph nodes become mechanically stiff as immune cells proliferate within their encapsulated environments, and with resolution, they reestablish a soft, baseline state. We found that these mechanical changes in the microenvironment promote and then restrict T-cell activation and metabolic reprogramming. Sensing of tissue mechanics by T cells requires the mechanosensor YAP. Unlike in other cells where YAP promotes proliferation, YAP in T cells suppresses proliferation in a stiffness-dependent manner by directly restricting the translocation of NFAT into the nucleus. YAP regulates T-cell responses against viral infections and in autoimmune diabetes. Our work reveals a new paradigm whereby tissue mechanics fine-tunes adaptive immune responses in health and disease.
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). Furthermore, we found no difference in percentages of natural Foxp3+ Treg cells ( Fig. S2F) , or in skewed development of iTreg or Th17 cells ( Fig. S2F-S2G ) in comparing YAPcKO and control littermates.
Given that YAP protein is highly upregulated in effector T cells, we hypothesized that YAP was important for effector T-cell responses. Surprisingly, activating YAPcKO CD4+ T cells led to an increase in the proliferation compared to that of WT CD4+ T cells, with a decrease in ED50 by 1.5-fold ( Fig. 2A) . Activated YAPcKO T cells also secreted more IL-2 ( Fig. 2B) and showed a marked increase in activation markers, including CD69, CD25, and CD44 (Fig. 2C) . To confirm that YAP negatively regulates T-cell proliferation and activation, we performed a "rescue" experiment. We transduced the full-length cDNA for YAP (FL YAP) or a control vector into TCR transgenic OT-II YAPcKO T cells, then re-stimulated the transduced T cells with APCs plus a range of cognate ovalbumin peptide. YAP expression in YAPcKO T cells led to decreased proliferation, IL-2 production, and CD25 expression compared to vector control ( Fig. 2D-2F) . Together, these data establish YAP as a suppressor of T-cell activation and effector responses.
YAP inhibits antiviral T-cell effector response
YAP has been implicated in the innate immune response to viral infection 19 . Thus, we wondered whether YAP could influence adaptive immunity in viral infections. Using an adoptive transfer mouse model, we co-injected equal numbers of congenic, naïve WT and YAPcKO SMARTA T cells, and then infected the naïve recipient mice with a non-lethal dose of LCMV Armstrong (Fig. 3A) . We observed a significant proliferative advantage of YAPcKO SMARTA T cells versus control SMARTA T cells near the height of the response (Fig. 3B) , along with heightened activation markers and cytokine production ( Fig. 3C and Fig. S3A-B) . These results show a cell-intrinsic effect of YAP on suppressing T-cell effector responses to a viral infection.
To test whether YAP expression would "rescue" the observed phenotype, we expressed FL YAP or a control vector in YAPcKO SMARTA T cells and co-adoptively transferred them into CD45.1 mice infected with LCMV. We found that over-expression of YAP led to impaired T-cell expansion as compared to those receiving a control vector ( Fig. 3D) , consistent with our in vitro data, along with decreased IFN-production and CD44 expression ( Fig. 3E) . These results demonstrate that expression of FL YAP rescues the phenotype in YAP-deficient T cells. Thus, YAP inhibits the T-cell response to a viral infection.
YAP inhibits metabolic reprogramming of activated T cells
In other cell types, YAP plays a role downstream of metabolic sensors to allow proliferation only when there are ample metabolic resources 22 . YAP activity can also regulate the metabolic state of a cell to support a proliferative program 23, 24 . The metabolic state of T cells is tightly regulated and central to their role in the immune response. To determine whether a metabolic link exists between YAP and T cell effector functions, we used extracellular flux analysis to measure the levels of glycolysis and oxidative phosphorylation (OXPHOS) in WT and YAPcKO T cells. We observed an increase in glycolytic capacity in activated YAPcKO T cells as compared to littermate controls ( Fig. 4A ). There were no differences in basal glucose uptake or basal glycolysis ( Fig. S4B) , which was confirmed using the fluorescent glucose analog 2-NBDG ( Fig. S4A) . Meanwhile, YAPcKO T cells exhibited a greater basal level of oxygen consumption rate (OCR) and maximal respiration capacity compared to WT cells ( Fig. S4C) . Absence of YAP in T cells also led to elevated spare respiratory capacity (SRC), an indicator of the mitochondrial ability to respond to stress 25 (Fig. 4B) . Effector WT and YAPcKO T cells were notably different in regards to basal ECAR/OCR ratio and in their maximal glycolytic and respiratory capacity ( Fig. S4E) . On the other hand, we saw the basal ECAR and OCR of naïve cells were nearly identical, consistent with YAP not being expressed in naïve T cells ( Fig. S4D and S4E) . We found an increase in mitochondrial staining in YAPcKO effector T cells compared to WT T cells ( Fig. 4C) , which could explain the increased respiratory capacity. We also found a higher mitochondrial membrane potential in YAPcKO effector T cells compared to that of WT T cells ( Fig. 4D) , which has been linked to increased ATP production and T-cell effector function 26 . Thus, YAP plays a role upstream of the metabolic program of effector T cells.
To gain further insight into the metabolic regulation, we measured polar metabolite levels in cultured T cells. WT and YAPcKO effector T cells showed large differences, especially as compared to naïve T cells ( Fig.  4E) . Metabolites that separate WT and YAPcKO effector T cells included the ADP/ATP and AMP/ATP ratios, amino acids, citric acid cycle intermediates, and nucleotides ( Fig. S4G) . We also observed significant products of metabolic activity, including elevated intracellular lactate and ATP (Fig. S4F) . The citric acid (TCA) cycle fuels OXPHOS, and so we examined TCA cycle intermediates and found a substantial increase in YAPcKO T cells as compared with controls ( Fig. 4F) . We wondered if YAPcKO effector T cells had more TCA cycle intermediates because of an increased rate of TCA cycling. To address this question, we used a metabolic tracing approach. We incubated effector T cells with 13 C-glucose or 13 C-glutamine and measured differences in mass isotopomer distributions between activated WT and YAPcKO T cells. We did not detect a significant difference in the isotopomeric labeling of citrate for 13 C-glucose-treated or 13 C-glutamine-treated samples, indicating that YAPcKO T cells had similar rates of TCA cycling to WT T cells ( Fig. S4H) . Indeed, the fractional contribution of labeled glucose to isotopologues of TCA metabolites was mostly similar between WT and YAPcKO T cells (Fig. S4I) . These labeling results suggest that YAPcKO T cells have more mitochondrial biogenesis rather than enhanced mitochondrial function. Altogether, these data indicate that YAP inhibits pathways of mitochondrial metabolism.
YAP coordinates mTOR activity and amino acid metabolism
Our metabolomics data revealed that YAPcKO effector T cells had higher intracellular amounts of several amino acids, including serine, glycine, asparagine, and leucine, all of which have been implicated in Tcell effector function and proliferation ( Fig. 4G and Fig. S5A ) 27, 28 . In line with the intracellular data, the abundance of these amino acids in the media was markedly reduced in the supernatant of cultured YAPcKO T cells as compared with WT controls (Fig. S5B) . CD98 (SLC3A2) forms a complex with LAT1 (SLC7A5) for the import of several amino acids, including leucine. Staining for cell-surface CD98 revealed that it was more highly expressed in YAPcKO effector T cells than WT controls ( Fig. 4H) . These data show that during T-cell activation, YAPcKO T cells imported more amino acids from the extracellular environment. Additionally, amino acid metabolism has been closely linked to mTOR signaling 29 . To test the involvement of mTOR in YAP-mediated effects on T cells, we examined downstream targets of mTOR in effector T cells. We found phosphorylation of S6 (p-S6) was greater in YAPcKO effector T cells compared to that of WT cells (Fig. 4H) .
To test whether elevated amino acid transport and mTOR activity also held true in an in vivo setting, we measured the expression of CD98 and p-S6 in adoptively co-transferred SMARTA T cells (WT and YAPcKO) after 5 days of infection with LCMV. YAPcKO SMARTA effector T cells exhibited greater CD98 and p-S6 expression than controls ( Fig. 4I) . Overall, our data show YAP dampens the T-cell response by downregulating mTOR signaling, and amino acid metabolism and transport.
YAP inhibits NFAT activity and translocation into the nucleus
Regulation of many metabolic changes in effector T cells have largely been attributed to transcription driven by the Nuclear Factor of Activated T cells (NFAT) 30, 31 . Furthermore, store-operated calcium entry and calcineurin regulate mitochondrial activity in an NFAT-dependent manner 32 . Upon triggering of the T-cell receptor, NFAT1 and NFAT2 travel into the nucleus and drive transcription, one of the targets being IL-2. Given the metabolic changes and the increased IL-2 expression of YAPcKO T cells, we studied the activation of NFAT1 and NFAT2. YAP-deficient effector T cells exhibited greater NFAT1 nuclear localization as compared with WT controls, but not NFAT2 ( Fig. 5A and S6A) . We sought next to understand how YAP controls NFAT localization.
IQGAP1 is a cytoplasmic scaffold protein that interacts with over 100 partner molecules. In T cells, IQGAP1 sequesters NFAT1 in the cytoplasm and participates in regulating its transit to the nucleus 33 . IQGAP1 was recently shown to interact with YAP and regulate its nuclear translocation as well 34 . We hypothesized that in T cells YAP could regulate the ability of IQGAP1 to bind to phosphorylated NFAT1, and thus regulate NFAT1 nuclear translocation. We made mutants of YAP ( Fig. 5B) and tested their interactions with IQGAP1 and their effects on NFAT translocation. We found that significantly more NFAT1 binds to IQGAP1 in YAPcKO T cells expressing FL YAP as compared to a control vector, suggesting that the presence of YAP augments the interaction between IQGAP1 and NFAT (Fig. 5C) . In the canonical Hippo pathway that regulates YAP, the LATS1/2 kinases phosphorylate YAP to sequester it in the cytoplasm. We mutated four LATS1/2targeted serine sites to alanine (YAP 4SA). Another modification that controls YAP activation is O-linked glycosylation, which is required for nuclear transport 35 , of one of the 4SA serines. YAPcKO T cells expressing YAP 4SA had significantly more NFAT1 associated with IQGAP1 compared to those expressing the control vector, and similar levels of bound NFAT1 as T cells expressing FL YAP (Fig. 5C) . This result shows that YAP influences the IQGAP-NFAT interaction, and this effect is not regulated by the canonical Hippo pathway or Olinked glycosylation in T cells. We further mutated serine 384 into alanine in addition to the mutations in YAP 4SA and termed this mutant YAP 5SA. This serine had been shown to be regulate degradation of YAP in other systems 36 . In contrast to YAP 4SA, YAPcKO T cells expressing YAP 5SA failed to keep NFAT1 coupled to IQGAP1 (Fig. 5C) . This result shows that serine 384 of YAP is essential to regulating NFAT activity through IQGAP1. The amino terminal, TEAD-binding domain (TBD) plays a critical role in the transcriptional regulation enacted by YAP in other systems, but the TBD is not necessarily required for all YAP-associated biology 19 . To explore whether the TEAD-binding domain of YAP was required for IQGAP regulation of NFAT1, we expressed YAPΔTBD in YAPcKO T cells and found that there were similar amounts of phosphorylated NFAT1 bound to IQGAP1 as compared to T cells transduced with FL YAP or YAP 4SA (Fig.  5C) . Thus, the YAP TBD is not required for regulating IQGAP1-NFAT1 interactions. Taken together, these results show that YAP regulates the interaction of IQGAP1 with NFAT1 in T cells, and that Ser384 of YAP plays a central role.
To assess whether YAP could inhibit NFAT1 nuclear localization we transduced the YAP constructs or control vector into YAPcKO T cells and then imaged for NFAT, YAP, and nuclear DNA. In YAPcKO cells expressing FL YAP, YAP 4SA, or YAPΔTBD, NFAT was excluded from the nucleus to a similar degree ( Fig.  5D-5E) . In contrast, we saw no restriction of NFAT localization to the nucleus with the YAP 5SA construct, which was similar to cells transduced with the control vector. Thus, YAP regulates sequestration of NFAT from the nucleus, and YAP Ser384 is important for this interaction. Despite the potential role of YAP Ser384 to regulate degradation in other systems, we saw no notable differences in YAP expression between YAP 4SA and YAP 5SA expressed in YAPcKO T cells ( Fig. 5D and Fig. S6B) . Thus, the trafficking of NFAT to the nucleus in T cells depends on Ser384 in YAP, but not the TBD, or the four serine phopshorylation sites in YAP 4SA. We assessed the biological impact of these YAP constructs and their regulation of NFAT on the suppression of proliferation of CD4+ T cells. YAPcKO T cells transduced with FL YAP or YAPΔTBD (i.e., those with intact Ser384) proliferated less than cells transduced with control vector or YAP 5SA ( Fig. S6C and D) . These results offer biological validation of the impact of YAP and its Ser384 in regulating NFAT1.
We questioned whether the role YAP played in suppressing T-cell responses was primarily mediated through NFAT. YAP in other systems regulates transcription through interaction with TEADs factors in the nucleus. In T cells, however, YAP-mediated suppression of responses was associated with cytoplasmic, not nuclear, localization (Fig. S6B) . Furthermore, deletion of the TBD of YAP did not affect interaction with IQGAP1, translocation of NFAT to the nucleus, translocation of YAP to the nucleus, or proliferative responses of T cells. To identify any potential non-NFAT influence on YAP, we employed a strategy to modestly suppress NFAT while comparing activation of T cells from WT and YAPcKO mice. If YAP played an inhibitory role aside from on NFAT, we would expect to see WT T cells inhibited beyond YAPcKO T cells at all levels of NFAT suppression. We stimulated T cells using a modest antigen dose to allow for suppression, co-cultured with calcinuerin inhibitor cyclosporine-A (CsA). In the absence of CsA, YAPcKO T cells showed greater activation than WT controls. At low doses of CsA (10-25 nM), while activation was mostly still intact, YAPcKO T cells showed a diminishment of CD25 and CD98 expression to match the levels of WT effector T cells ( Fig. 5F-5G) . Above this dose, we observed that WT and YAPcKO T cells showed a lockstep decrease in effector responses, down to complete suppression of activation at high CsA. Any YAP-dependent, NFAT1independent suppression of T-cell activation should not allow this effect. Thus, these data indicate that YAP suppresses T-cell effector responses through an NFAT-dependent mechanism.
Sensing mechanical forces requires YAP
YAP is established as a key convergence point for mechanosignaling in many, and to test whether T cells sense mechanics through YAP, we returned to the system developed in Fig. 1 and first examined whether substrate stiffness influenced NFAT nuclear localization. We activated SMARTA T cells with peptide-pulsed APCs atop soft (4 kPa) or stiff (40 kPa) scaffolds. We found significantly increased nuclear NFAT1 in T cells activated on the stiff surface as compared to soft, suggesting that mechanical forces supervise NFAT1 activity (Fig. 6A) . In addition, CD25 and CD98, targets of NFAT, were upregulated in T cells activated on stiff surfaces compared to that of soft surfaces (Fig. 6C) .
These data led us to hypothesize that the mechanical microenvironment controlled NFAT activity in T cells through YAP. We compared NFAT1 nuclear/cytoplasmic expression in YAPcKO SMARTA T cells activated on soft and stiff surfaces. Importantly, the effect of elastic modulus on NFAT1 localization was entirely abolished in YAPcKO T cells (Fig. 6B) . Additionally, YAPcKO T cells exhibited similar expression of NFAT1 targets CD25 and CD98 when exposed to stiff and soft microenvironments (Fig. 6D) . These results indicate that NFAT activity and its downstream targets are dependent on YAP in T cells. YAPcKO T cells demonstrated similar proliferation kinetics to WT T cells on stiff substrates, further suggesting that mechanicsdependent T-cell proliferation is mediated by YAP (Fig. 6E) . To test if substrate stiffness had a direct effect on the amount of YAP bound to IQGAP1 to control NFAT activity, we recovered T cells from soft and stiff scaffolds after activation and co-immunoprecipitated proteins complexed with IQGAP1. When we probed for the presence of NFAT1, we discovered that less NFAT1 was bound to IQGAP1 in T cells seeded on stiff hydrogels versus in T cells seeded on soft hydrogels (Fig. 6F) . In contrast, NFAT1 was found complexed with IQGAP1 to a similar degree in YAPcKO T cells regardless of substrate stiffness (Fig. 6G) . Thus, the mechanical environment influences NFAT nuclear localization, activation markers, proliferation, and IQGAP1-NFAT interaction in a YAP-dependent manner.
Activated T cells leaving an activated LN may find themselves circulating into LNs where autoantigens mimic a cognate stimulus. Molecular mimickry is indeed postulated to be a major driver of autoimmunity that becomes primed during infections and arises clinically shortly thereafter, for example, Type 1 diabetes. Our model would suggest that the mechanical softness of the unactivated LN should inhibit activated T cells bearing YAP and suppress autoimmunity. To test this hypothesis, we assessed whether self-reactive YAP-deficient CD4+ T cells could ignore the soft, inhibitory mechanical cues of naïve LN in vivo. We measured the ability of YAP to regulate Type 1 diabetes in NOD.SCID mice, which lack functional T and B cells. T cells bearing the islet-specific TCR BDC2.5 are diabetogenic when transferred into NOD.SCID mice, an outcome mediated by production of IFN-by activated T cells 37 . We completed YAP knockdown by retrovirally transducing shRNA in BDC2.5 cells and verified that YAP protein was depleted (Fig. S6E) . We adoptively transferred T cells transduced with YAP shRNA or control shRNA into NOD.SCID mice (Fig. 6G) . We found that mice receiving T cells depleted of YAP developed diabetes faster than with those receiving control T cells (Fig. 6I) . YAPdepleted BDC2.5 T cells developed into more IFN-+ T cells on a per-cell basis than controls (Fig. 6H) , proliferated to a greater extent in response to cognate peptide, and made more IL-2 (Fig. S6F) . These results indicate that sensing the mechanical microenvironment in LN requires YAP to slow the progression of autoimmune disease. Taken all together, our data demonstrate the critical role of YAP as a mechanosensor that links tissue mechanics to regulation of the T-cell effector response through NFAT sequestration and metabolic control.
DISCUSSION
Here, we identify a new physiological feedback mechanism whereby microenvironmental cues guide Tcell effector responses. These mechanical signals are separate from the mechanical forces exerted on the TCR, and thus T cells appear to be capable of independently sensing forces at both the molecular scale and tissues scale. The pathophysiological implication of these findings may extend from infections to autoimmunity to cancer, each of which shows considerable alterations in tissue mechanics. In this paper, we study autoimmunity and infection models, and show dramatic changes in the mechanics of the lymph nodes. Mechanical changes in LNs occur early due to migrating, activated dendritic cells that induce alterations in fibroblastic reticular cells 38, 39 , and later from proliferation of lymphocytes within the encapsulated, confined environment. We describe a YAP-mediated pathway by which a mechanically stiff microenvironment enhances T-cell activation and metabolic reprogramming as YAP enters the nucleus and allows for NFAT activation. As activated T cells emigrate from the LN and the pathogen is cleared, the stiffness of LNs starts to fall. In the mechanically soft microenvironment, YAP restrains T-cell activation and metabolic reprogramming as YAP enforces sequestration of NFAT in the cytoplasm by IQGAP1 (Fig. S6E) . Thus, YAP controls the T cell's ability to recognize the rising and falling micromechanical environment, thereby modulating the metabolic state accordingly. The sensing of mechanics is not strictly dichotomous, as tissue mechanics offer a continuum of rigidity. Our work thus identifies a new mechanical checkpoint by which the natural cycles of tissue mechanical changes directly fine-tune T-cell activation and cellular bioenergetics.
In studying the mechanical cues offered by natural tissues, our work quantified the mechanical state of LNs associated with acute viral infection. In reality, the microenvironment of activated LNs and tissues comprises not only changes in stiffness, but also inflammatory cytokines, dendritic cells and their costimulatory potential, fibroblastic reticular cells and their chemokine expression, and more. Lacking an experimental approach to influence only mechanics of tissues but not these other consequences of innate immune activation led us to choose a combination of in vivo and in vitro approaches in this paper.
A key finding in this paper is the mechanism by which YAP influences NFAT trafficking to the nucleus, which differs from the other ways that YAP enacts its roles 40 . In resting T cells, IQGAP1 holds NFAT in a complex that includes many other partners 33 . We show here that YAP enforces sequestration of NFAT by controlling IQGAP1's ability to bind to NFAT. Importantly, the regulation of NFAT on mechanically defined substrates requires YAP. Our work offers potential follow up: IQGAP1 is known to regulate actin cytoskeleton dynamics in T cells 41 and many other cells 42 . Future investigation into how environmental stiffness regulates IQGAP's ability to control the actin cytoskeleton may shed more light into the mechanosignaling mechanisms of YAP in general.
YAP collects critical regulatory cues to identify environments bearing favorable metabolic substrates and mechanics. We show that YAP also plays a role in the highly motile cells of the immune system, providing an accelerator or brake on T-cell responses as they encounter infected and autoimmune tissue microenvironments. The results presented here offer clues of an orchestrated, molecular pathway allowing mechanical stiffness to modulate T-cell activation and metabolism. Our findings also newly reveal that the adaptive immune response is fine-tuned in accordance with physiological and pathophysiological changes in tissue mechanics.
